Breaking Down Big Pharma: The Opioid Crisis, Insurance & MAHA | Brigham Buhler
Kelly LeVequePublished on March 19, 2025
Summary authored by editor@wellifi.com
TLDR Summary
In a recent podcast episode, Brigham Buer discussed the monetization of chronic diseases within the healthcare system, emphasizing the need for preventive health measures and the role of compounding pharmacies in providing affordable medication. By advocating for personal health accountability and systemic reform, individuals can challenge the status quo and seek better health outcomes.
Key Points
- Monetization of chronic diseases leads to a lack of preventive measures in healthcare.
- The opioid crisis exemplifies the failures of the pharmaceutical industry and insurance companies.
- Compounding pharmacies offer customized medications that can be more affordable than traditional options.
- Individuals can take control of their health by prioritizing lifestyle changes and seeking preventive care.
Understanding the Health Care System: Dismantling Chronic Disease Monetization
In a recent episode of the Be Well by Kelly podcast, host Kelly LeVeque spoke with Brigham Buer, a former pharmaceutical and medical device industry insider, about the challenges and corruption within the health care system. Their discussion focused on the monetization of chronic diseases and the lack of incentives to promote preventive health measures.
The Dark Side of Health Care
As Buer shared his journey from working in pharmaceuticals to owning a compounding pharmacy, he highlighted the troubling truth that the health care system profits from chronic illnesses rather than encouraging prevention. With numerous people relying on prescription medications, there’s little incentive for the industry to promote health and wellness solutions.
A Personal Journey
Buer recounted how his brother's tragic death from opioid addiction prompted him to seek solutions outside of conventional medicine. Witnessing firsthand the devastation caused by opioid prescriptions, he became an advocate for non-addictive alternatives and established a compounding pharmacy to provide these options.
Breaking Down the Health Care System
During the discussion, Buer explained the intricate relationship between pharmaceutical companies, insurance providers, and the FDA. He emphasized that:
- Pharmaceutical companies often profit from chronic illnesses, with insurance companies benefiting from prescriptions rather than preventative measures.
- The average American is on multiple prescription drugs, but this is often driven by financial incentives rather than patient health outcomes.
- Compounding pharmacies can provide customized medications that are often more affordable than traditional pharmaceutical options.
Key Issues in the Health Care System
Some major points discussed included:
- The failure of the FDA to protect consumers adequately, allowing harmful drugs to enter the market.
- The influence of Pharmacy Benefit Managers (PBMs) in the pricing and distribution of medications.
- The systemic issues that prevent doctors from offering personalized patient care.
Pathways to Change
To empower individuals and improve health outcomes, Buer offered several actionable steps:
- Take control of your health by prioritizing preventive measures such as regular exercise, balanced nutrition, and adequate sleep.
- Seek out comprehensive blood work to understand your health baseline and guide personal health decisions.
- Consider cash pay options for medical services and medications, as they can often be cheaper than going through insurance.
- Advocate for legislative changes that promote transparency and accountability in the health care system.
Conclusion
The conversation with Brigham Buer sheds light on the complex challenges facing the health care system today. By understanding the motivations behind the industry’s structure and advocating for change, individuals can take proactive steps towards better health outcomes and challenge the status quo. For more insights and resources, visit the Be Well by Kelly website.